Ebola Outbreak in Congo Sparks Global Concern
BUNIA, Congo — On Tuesday, the head of the World Health Organization (WHO) raised alarms about the rapid spread of a rare type of Ebola known as Bundibugyo in eastern Congo. Reports indicate 134 suspected deaths and over 500 cases.
The outbreak went unrecognized for several weeks after the first death was recorded. Doctors initially tested for a more common type of Ebola and found nothing. This particular strain currently lacks any approved treatments or vaccines, making the situation even more pressing.
At the hospital in Bunia, where the initial case was reported, health workers in protective gear interacted with residents wearing basic fabric masks. Noëla Lumo, a concerned local, shared her fears: “I know the consequences of Ebola, I know what it’s like.”
Congo is anticipating the arrival of experimental vaccines from the U.S. and the U.K., created by researchers at Oxford. Jean-Jacques Muyembe, an expert from the National Institute of Biomedical Research, conveyed optimism: “We will administer the vaccine and see who develops the disease.” However, experts caution that implementing such measures will take time.
WHO Director-General Tedros Adhanom Ghebreyesus expressed deep concern about the outbreak’s scale, particularly noting urban cases, healthcare worker fatalities, and significant population movement. As of now, Congo has confirmed 30 cases, and Uganda reported two confirmed cases, including one death in its capital, Kampala, involving travelers from Congo.
Ongoing Efforts and Challenges
The WHO has labeled this outbreak a public health emergency of international concern, requiring a coordinated response. Aid resources are being directed towards two affected provinces near Uganda, although armed rebels control parts of eastern Congo, creating complications for aid distribution.
Dr. Anne Ancia, leading the WHO team in Congo, mentioned that authorities have not yet identified “patient zero.” She noted that the Ervebo vaccine, typically used for different Ebola strains, is being evaluated, but any approved vaccine might take two months to be available.
“I don’t see us finishing this outbreak in two months,” she said. Currently, the U.S. Centers for Disease Control and Prevention and the Africa Centers for Disease Control are not on the ground, but organizations like Doctors Without Borders and the Red Cross are actively engaged.
UNICEF reported sending an initial shipment of 16 tons of relief supplies to Bunia, mainly consisting of disinfectants, personal protective gear, and water purification equipment, intended for three treatment centers in Ituri province.
Confirmed cases have emerged in various locations, including Bunia, Goma, and other nearby towns, amounting to a combined population of over a million people. An American doctor, Dr. Peter Stafford, is among those treated in Bunia, according to the Christian organization with which he works. Tedros later confirmed that an American individual tested positive and has since been sent to Germany.
Panic and Fear Across Communities
Ebola, which spreads through bodily fluids, can cause severe symptoms that often lead to death. Previous outbreaks have highlighted how individuals contracted the virus during funeral practices, leading to extensive infections.
Dr. Craig Spencer, an associate professor who survived Ebola years ago, noted how the disease is especially difficult because it disproportionately affects caregivers. Growing panic has been reported in Bunia’s neighborhoods, prompting local authorities to advise residents on hygiene and safety during funerals.
“It’s truly sad and painful because we’ve already been through a security crisis, and now Ebola is here too,” expressed resident Justin Ndasi. “We have to protect ourselves to avoid this epidemic.”
The key challenge lies in breaking the virus’s transmission chain, as underscored by Muyembe. Historically, Congo’s Ebola outbreaks have been managed through public health measures.
Slow Response Due to Testing Issues
Congo identified the first death from this virus on April 24, but confirmation was delayed for weeks—this meant the outbreak escalated. After another illness was reported on April 26, samples sent for testing yielded false negatives, which prolonged the response and worsened the situation.
Dr. Richard Kitenge from the health ministry indicated that initial tests focused on the common Zaire strain. The WHO received notifications about multiple deaths by May 5, yet the actual identification of the strain happened on May 14.
“Our surveillance system didn’t work,” acknowledged Muyembe, emphasizing that the laboratory in Bunia should have persisted in testing. Only labs in Kinshasa and Goma have the capability to test for Bundibugyo Ebola.
M23’s permanent secretary stated that their administration in Goma has established entry and exit points to manage the situation and emphasized the need for the community to resume daily activities cautiously.
Critics of past U.S. administration decisions, such as the reduction of aid affecting surveillance systems designed to detect outbreaks, highlighted the broader implications of insufficient funding. The State Department has reported contributing $13 million to the ongoing response efforts.
Dr. Ancia in Bunia remarked on the negative impact caused by funding cuts, complicating the situation on the ground. With limited resources, Doctors Without Borders identified suspected cases but faced numerous challenges due to overcrowded facilities. The situation is indeed troubling.
